Editor’s Note: As the 340B program draws increased attention from researchers, policymakers and commentators, 340B Report has launched a new [...] …
General
A CVS Health executive told shareholders last week that mounting pressures on the company’s 340B business were creating a “headwind” [...] …
Please Login or Become a Paid Subscriber to View this Content
An India-based drugmaker recently announced 340B refunds for covered entities that purchased five medications while a California-based drugmaker introduced 22 [...] …
Please Login or Become a Paid Subscriber to View this Content
340B stakeholder groups offered mixed reactions to a U.S. Senate bipartisan working group’s long-awaited introduction of the SUSTAIN 340B Act, [...] …
Please Login or Become a Paid Subscriber to View this Content
New federal policies intended to lower drug prices are inadvertently reducing 340B savings, forcing some covered entities to make do [...] …
Please Login or Become a Paid Subscriber to View this Content
A Texas federal judge recently struck down part of an HHS rule that changed calculations for the Medicare disproportionate share [...] …
Please Login or Become a Paid Subscriber to View this Content
A bipartisan Senate working group on Wednesday released its long-awaited plan to overhaul the 340B drug discount program, known as [...] …
Please Login or Become a Paid Subscriber to View this Content
A large California drugmaker recently announced it will soon require all covered entities to submit claims-level data for 340B purchases, [...] …
Please Login or Become a Paid Subscriber to View this Content
340B stakeholders offered competing reactions Friday to HRSA’s new 340B rebate model pilot, with hospital and health center groups condemning [...] …
Please Login or Become a Paid Subscriber to View this Content
The Trump administration on Tuesday announced plans to end subsidies that help lower Medicare drug premiums—a program which it argued [...] …
